Blog
RSS FeedPosted by Michael Wonder on 06 Jul 2020
Better protection against meningococcal and pneumococcal diseases
6 July 2020 - The National Immunisation Program has been amended from 1 July 2020 to improve protection for those most ...
Posted by Michael Wonder on 01 Jul 2020
PBS listings to benefit Australians with type 2 diabetes and small cell lung cancer, emergency dispensing measures of PBS medicines extended
30 June 2020 - The importance of the Pharmaceutical Benefits Scheme has been underlined with new and amended medicines listings on ...
Posted by Michael Wonder on 30 Jun 2020
Schedule of Pharmaceutical Benefits - 1 July 2020
1 July 2020 - The July 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Jun 2020
New Zealand Pharmaceutical Schedule - 1 July 2020
1 July 2020 - The July 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 02 Jun 2020
Summary of PBS opioid listings for the treatment of pain as of 1 June 2020
2 June 2020 - A number of changes were made to the PBS listings for opioid medicines for the treatment of ...
Posted by Michael Wonder on 02 Jun 2020
Estimating the cost of delayed generic drug entry to Medicaid
1 June 2020 - Delays in market entry of generic drugs are common. ...
Posted by Michael Wonder on 01 Jun 2020
Expanded PBS medicines listings to provide new treatment options for over 170,000 asthmatics, and new hope for blood cancer patients
1 June 2020 - Australians with asthma and multiple myeloma will have broader access to life changing medicines as a result ...
Posted by Michael Wonder on 31 May 2020
Schedule of Pharmaceutical Benefits - 1 June 2020
1 June 2020 - The June 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2020
Greater flexibility for Australians with severe asthma with reimbursement of at-home
1 June 2020 - Greater flexibility for Australians with severe asthma with reimbursement of at-home, self-administration delivery of Nucala (mepolizumab) ...
Posted by Michael Wonder on 31 May 2020
New Zealand Pharmaceutical Schedule - 1 June 2020
1 June 2020 - The June 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 May 2020
New biosimilar trastuzumab on the PBS - information for health professionals and patients
26 May 2020 - A biosimilar brand of trastuzumab (Trazimera) was listed on the PBS on 1 May 2020. ...
Posted by Michael Wonder on 21 May 2020
Proposal to award sole supply of infliximab in DHB hospitals
21 May 2020 - PHARMAC is proposing to award sole supply of infliximab, a biologic medicine used to treat a ...
Posted by Michael Wonder on 20 May 2020
Atomoxetine – further delay in change of funded brand and open access
20 May 2020 - PHARMAC is advising all interested parties that there is a further one-month delay in the listing ...
Posted by Michael Wonder on 14 May 2020
Japan OKs public insurance coverage for SMA drug Zolgensma
13 May 2020 - A panel that advises the health minister approved on Wednesday coverage for Novartis' spinal muscular atrophy ...
Posted by Michael Wonder on 04 May 2020
New listings welcomed amongst COVID backdrop
4 May 2020 - Medicines Australia welcomes Friday’s announcement by Minister for Health the Hon Greg Hunt on the PBS ...